PB2106: REDUCTION OF METHOTREXATE (MTX) LEVELS AFTER GLUCARPIDASE IN PATIENTS WITH DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL) AT RISK OF CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT WHO RECEIVE HDMTX: PHASE 2.

Autor: De La Fuente, A., Peñalver, F. J., Herrera, P., Cordoba, R., Martinez Chamorro, C., Olave, M. T., Jarque, I., Navarro, M. B., Estévez, M.
Zdroj: HemaSphere; 2022 Supplement 3, Vol. 6, p1977-1978, 2p
Databáze: Complementary Index
Externí odkaz: